Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) have earned a consensus rating of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $29.00.

Several equities analysts have recently commented on KMTS shares. Piper Sandler increased their price target on shares of Kestra Medical Technologies from $27.00 to $30.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Wall Street Zen downgraded Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Sunday, September 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Kestra Medical Technologies in a report on Wednesday, December 24th. The Goldman Sachs Group set a $24.00 price target on Kestra Medical Technologies in a research report on Friday, January 16th. Finally, Stifel Nicolaus set a $30.00 price objective on Kestra Medical Technologies in a research note on Friday, December 12th.

Insider Activity

In other Kestra Medical Technologies news, insider Traci S. Umberger sold 10,500 shares of the firm’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $26.69, for a total value of $280,245.00. Following the transaction, the insider owned 136,633 shares of the company’s stock, valued at $3,646,734.77. This trade represents a 7.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Brian Daniel Webster sold 15,000 shares of Kestra Medical Technologies stock in a transaction that occurred on Thursday, January 15th. The shares were sold at an average price of $22.80, for a total value of $342,000.00. Following the completion of the transaction, the insider owned 394,786 shares of the company’s stock, valued at approximately $9,001,120.80. The trade was a 3.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 40,500 shares of company stock valued at $1,021,095 over the last ninety days. Company insiders own 3.60% of the company’s stock.

Institutional Trading of Kestra Medical Technologies

Hedge funds have recently made changes to their positions in the stock. Farther Finance Advisors LLC bought a new position in Kestra Medical Technologies during the 4th quarter worth $31,000. China Universal Asset Management Co. Ltd. acquired a new position in shares of Kestra Medical Technologies during the third quarter valued at $48,000. Police & Firemen s Retirement System of New Jersey bought a new position in shares of Kestra Medical Technologies during the second quarter worth about $54,000. BNP Paribas Financial Markets increased its holdings in shares of Kestra Medical Technologies by 148.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,738 shares of the company’s stock worth $65,000 after acquiring an additional 1,638 shares during the period. Finally, Brown Brothers Harriman & Co. lifted its position in Kestra Medical Technologies by 26.8% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 3,104 shares of the company’s stock valued at $74,000 after purchasing an additional 656 shares during the last quarter.

Kestra Medical Technologies Trading Down 0.4%

NASDAQ KMTS opened at $24.60 on Friday. The company has a market capitalization of $1.44 billion and a price-to-earnings ratio of -7.76. The company has a debt-to-equity ratio of 0.26, a current ratio of 5.47 and a quick ratio of 5.47. Kestra Medical Technologies has a 12 month low of $13.25 and a 12 month high of $30.00. The company’s fifty day moving average price is $25.47 and its two-hundred day moving average price is $22.36.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator (“WCD”) used to protect patients at an elevated risk of sudden cardiac arrest (“SCA”), a major public health problem that accounts for approximately 50% of all cardiovascular deaths in the U.S.